TabletAnti Diabetic

Dapagliflozin + Sitagliptin

Dapagliflozin + Sitagliptin · SGLT2 inhibitor and DPP-4 inhibitor antidiabetic combination

TabletAnti Diabetic

Dapagliflozin + SitagliptinProspero Healthcare

This tablet contains Dapagliflozin + Sitagliptin and belongs to the group of SGLT2 inhibitor and DPP-4 inhibitor antidiabetic combination products. It is used in the management of type 2 diabetes mellitus, in line with standard clinical indications for this class.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Dapagliflozin + Sitagliptin
Available strengthsIndicative: 10 mg + 100 mg
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: SGLT2 inhibitor and DPP-4 inhibitor antidiabetic combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category